Hill, JC ORCID: https://orcid.org/0000-0001-6246-1409, Scott, IC ORCID: https://orcid.org/0000-0002-1268-9808, Mccray, G ORCID: https://orcid.org/0000-0002-0728-5171, Lancaster, GA ORCID: https://orcid.org/0000-0002-6957-6177 and Foster, NE ORCID: https://orcid.org/0000-0003-4429-9756 (2020) Validation of the Musculoskeletal Health Questionnaire (MSK-HQ) in Primary Care Patients with Musculoskeletal Pain. Seminars in Arthritis and Rheumatism. (In Press)

[img] Text
MSK-HQ Primary Care Seminars AR Revised_Untracked.docx - Accepted Version
Restricted to Repository staff only until 25 June 2021.
Available under License Creative Commons Attribution Non-commercial.

Download (131kB)


To evaluate the responsiveness, and concurrent validity of the Musculoskeletal Health Questionnaire (MSK-HQ) in UK primary care patients with common musculoskeletal (MSK) pain presentations.

A secondary analysis of a primary care pilot randomised trial (STarT MSK) was performed. In 524 people consulting with back, neck, shoulder, knee, or multi-site pain, the following were recorded at 0/6 months: MSK-HQ, EQ-5D-5L, Roland-Morris Disability Questionnaire (RMDQ; back pain), Neck Disability Index (NDI), Shoulder Pain and Disability Index (SPADI), Knee Injury and Outcome Score (KOOS), Short-Form-12 (SF-12; multisite pain). At 6-months, patients self-rated their global change in MSK condition, from -5 (“very much worse”) to +5 (“completely recovered”). Receiver operating characteristic curves evaluated abilities of 6-month changes in each patient reported outcome measure (PROM) to discriminate between patients improving/not improving on global change scores, with Minimal Clinically Important Differences (MCID) calculated.

The MSK-HQ had a good ability to discriminate between MSK pain patients reporting global improvement vs. no improvement (area under the curve [AUC] 0.81; 95% CI 0.78, 0.85). Its discriminative ability was higher than the EQ-5D-5L (AUC 0.68; 95% CI 0.62, 0.73) and similar to site-specific PROMs. The MCID for the 6-month change in MSK-HQ was 5.5. The MSK-HQ had strong correlations with all PROMs, except SF-12 scores.

In primary care patients with common MSK pain presentations, the MSK-HQ was as good as existing pain-site specific PROMs at identifying people reporting global improvements in their MSK condition, and was better than the EQ-5D-5L.

Item Type: Article
Additional Information: The final version of this accepted manuscript will be available online at https://www.journals.elsevier.com/seminars-in-arthritis-and-rheumatism
Uncontrolled Keywords: Musculoskeletal, patient reported outcome measures, primary care, quality of life
Subjects: R Medicine > R Medicine (General)
R Medicine > RA Public aspects of medicine
R Medicine > RC Internal medicine
Divisions: Faculty of Medicine and Health Sciences > School of Primary, Community and Social Care
Depositing User: Symplectic
Date Deposited: 29 Jun 2020 14:34
Last Modified: 07 Jul 2020 15:17
URI: https://eprints.keele.ac.uk/id/eprint/8275

Actions (login required)

View Item View Item